Patient quality of life Resources

Incontinence-associated dermatitis (IAD) relates to skin breakdown from exposure to urine or faeces, and its management involves implementation of structured skin care regimens incorporating appropriate use of skin barrier products to protect the skin from exposure to moisture and irritants. Medi Derma-PRO Skin Protectant Ointment and Medi Derma-PRO Foam & Spray Incontinence Cleanser are part of the Total Barrier Protection™ (Medicareplus International) range indicated for management of moderate-to-severe IAD and other moisture-associated skin damage (MASD). This article summarises the findings of multi-centred patient evaluations of Medi Derma-PRO Skin Protectant Ointment and Medi Derma-PRO Foam & Spray Incontinence Cleanser, and aims to demonstrate the clinical and cost benefits of using these products for the prevention and management of MASD.

It is estimated that 1.5% of the adult population in the UK is currently living with a leg ulcer (Guest et al, 2015). There is substantial evidence to suggest that venous leg ulcers are being poorly managed with delays in assessment, poor primary dressing choice and suboptimal levels of compression contributing to the delay in wound healing (Gray et al, 2018). The bulk of leg ulcer care takes place within primary care (Guest, 2015). Despite there being considerable evidence to support the use of compression therapy and undertaking accurate leg ulcer assessment, this does not appear to always happen in practice. This paper looks at how one clinic improved healing outcomes and patient quality of life through holistic assessment, patient education, supported self-care and introducing compression wraps into the treatment regimen.